Chronic Spinal Cord Injury
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ONWARD MedicalNetherlands - Eindhoven
2 programsLIFT SystemN/A1 trial
LIFT SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BiocorpAXER-204
ONWARD MedicalLIFT System
ONWARD MedicalLIFT System
Clinical Trials (3)
Total enrollment: 134 patients across 3 trials
AXER-204 in Participants With Chronic Spinal Cord Injury
Start: Jul 2019Est. completion: Jun 202252 patients
Phase 1/2Completed
LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury
Start: Mar 2022Est. completion: Sep 202217 patients
N/ACompleted
The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury
Start: Jan 2021Est. completion: Sep 202265 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.